Kaloba Syrup

/ Dr. Samuelov

Adults and adolescents over the age of 12: 7.5 ml syrup three times per day.
Children aged between 6-11 years: 5 ml syrup three times per day.
Children aged between 1 – 5 years: 2.5 ml syrup three times per day.
Use in children under the age of one is not recommended as there are no adequate data.
Method of administration: Oral administration.
Kaloba Syrup is to be taken mornings, at midday and evenings.
A measuring cup with various markings is enclosed for dosing Kaloba Syrup.
The cup should be cleaned appropriately after use.
Continuation of treatment is recommended for several days after relief of symptoms, in order to prevent a relapse.
If the symptoms become worse or no improvement occurs after 7 days, a doctor must be consulted.
Treatment should not exceed 3 weeks.

Symptomatic treatment of acute bronchitis for adults and children form age of 1 years.
Traditional herbal medicinal product for use in the common cold for adults and children from age of 1 years.

Hypersensitivity to the active substance or to any of the excipients.
Kaloba syrup should not be taken in cases of severe hepatic diseases, as no sufficient experience is available in this area.
A doctor must be consulted if the condition does not improve within one week, with liver dysfunctions of different origin, or if fever, shortness of breath or bloody sputum occur.
Cases of liver damage and hepatitis have been reported in connection with the use of medicinal products containing Pelargonium, no casual relationship with the use of Kaloba syrup, has been established.
Paediatric population: Use in children under the age of one is not recommended as there are no adequate data.
For children under the age of two, a medical examination to determine the clinical picture should be undertaken prior to administration owing to the generally higher risk due to respiratory tract diseases.
For children between two and four years, a prior medical examination is necessary if they suffer from persistent or recurrent coughing.

Gastrointestinal complaints, such as stomach pain, heartburn, nausea or diarrhoea, are uncommon during the use of Kaloba Syrup.
In rare cases, slight gingival bleeding or nosebleeds may occur. Furthermore, hypersensitivity reactions (exanthema, urticaria, pruritus of the skin and mucous membranes) have been described in rare cases. Such reactions may occur even when taking the medicine for the first time.
In very rare cases, severe hypersensitivity reactions with facial swelling, dyspnoea and hypotension may occur.
Hepatic dysfunction of various aetiologies. No causal relationship with the use of Kaloba Syrup has been established. The frequency is not known.

None known to date.
In a placebo-controlled double-blind study in healthy volunteers, no interactions between the active substance in Kaloba® syrup for children and penicillin V were found.
There are no further investigations into interactions.

Pregnancy: Kaloba Syrup should not be taken during pregnancy as there is no sufficient experience available.
Lactation: Kaloba Syrup should not be taken during Lactation as there is no sufficient experience available. It is not known whether ingredients of the dry extract of Pelargonium sidoides roots or their metabolites pass into breast milk. A risk for the infant cannot be excluded.

No cases of overdose have been reported.

Storage: Storage condition: Do not store above 30°C. Note for storage after opening: Do not store more than 6 months and above 30°C. Bottles should be stored vertically, do not store in a lying position or upside down.